Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bodhi Tree Biotechnology (BDTB) EBIT (2024 - 2025)

Historic EBIT for Bodhi Tree Biotechnology (BDTB) over the last 2 years, with Q4 2025 value amounting to -$52949.0.

  • Bodhi Tree Biotechnology's EBIT rose 1825.96% to -$52949.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$135790.0, marking a year-over-year change of. This contributed to the annual value of -$147618.0 for FY2025, which is N/A changed from last year.
  • Bodhi Tree Biotechnology's EBIT amounted to -$52949.0 in Q4 2025, which was up 1825.96% from -$10687.0 recorded in Q3 2025.
  • Bodhi Tree Biotechnology's 5-year EBIT high stood at -$10687.0 for Q3 2025, and its period low was -$64777.0 during Q4 2024.